10-101775182-T-TCCCTGCCCAGCGCAGGGC

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM4BP6BS1BS2

The NM_033163.5(FGF8):​c.86_103dupGCCCTGCGCTGGGCAGGG​(p.Gly29_Arg34dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00265 in 1,548,090 control chromosomes in the GnomAD database, including 13 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0028 ( 13 hom. )

Consequence

FGF8
NM_033163.5 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 1.37
Variant links:
Genes affected
FGF8 (HGNC:3686): (fibroblast growth factor 8) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein is known to be a factor that supports androgen and anchorage independent growth of mammary tumor cells. Overexpression of this gene has been shown to increase tumor growth and angiogensis. The adult expression of this gene is restricted to testes and ovaries. Temporal and spatial pattern of this gene expression suggests its function as an embryonic epithelial factor. Studies of the mouse and chick homologs revealed roles in midbrain and limb development, organogenesis, embryo gastrulation and left-right axis determination. The alternative splicing of this gene results in four transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_033163.5.
BP6
Variant 10-101775182-T-TCCCTGCCCAGCGCAGGGC is Benign according to our data. Variant chr10-101775182-T-TCCCTGCCCAGCGCAGGGC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 545463.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=2, Benign=1}.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0017 (259/152254) while in subpopulation NFE AF = 0.00338 (230/68000). AF 95% confidence interval is 0.00302. There are 0 homozygotes in GnomAd4. There are 108 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 259 AD,Digenic gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGF8NM_033163.5 linkc.86_103dupGCCCTGCGCTGGGCAGGG p.Gly29_Arg34dup conservative_inframe_insertion Exon 3 of 6 ENST00000320185.7 NP_149353.1 P55075-4A1A515

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGF8ENST00000320185.7 linkc.86_103dupGCCCTGCGCTGGGCAGGG p.Gly29_Arg34dup conservative_inframe_insertion Exon 3 of 6 1 NM_033163.5 ENSP00000321797.2 P55075-4

Frequencies

GnomAD3 genomes
AF:
0.00170
AC:
259
AN:
152136
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00338
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00132
AC:
196
AN:
148156
AF XY:
0.00143
show subpopulations
Gnomad AFR exome
AF:
0.000575
Gnomad AMR exome
AF:
0.0000814
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000527
Gnomad NFE exome
AF:
0.00321
Gnomad OTH exome
AF:
0.000946
GnomAD4 exome
AF:
0.00275
AC:
3845
AN:
1395836
Hom.:
13
Cov.:
32
AF XY:
0.00272
AC XY:
1870
AN XY:
688444
show subpopulations
Gnomad4 AFR exome
AF:
0.000539
AC:
17
AN:
31540
Gnomad4 AMR exome
AF:
0.0000840
AC:
3
AN:
35726
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
25174
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
35734
Gnomad4 SAS exome
AF:
0.00
AC:
0
AN:
79154
Gnomad4 FIN exome
AF:
0.000671
AC:
32
AN:
47674
Gnomad4 NFE exome
AF:
0.00344
AC:
3713
AN:
1078860
Gnomad4 Remaining exome
AF:
0.00138
AC:
80
AN:
57808
Heterozygous variant carriers
0
171
343
514
686
857
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00170
AC:
259
AN:
152254
Hom.:
0
Cov.:
31
AF XY:
0.00145
AC XY:
108
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.000385
AC:
0.000385004
AN:
0.000385004
Gnomad4 AMR
AF:
0.000457
AC:
0.000457397
AN:
0.000457397
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.000283
AC:
0.000282646
AN:
0.000282646
Gnomad4 NFE
AF:
0.00338
AC:
0.00338235
AN:
0.00338235
Gnomad4 OTH
AF:
0.00142
AC:
0.00141911
AN:
0.00141911
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00174
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Jan 09, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 04, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In-frame duplication of six amino acids in a non-repeat region; This variant is associated with the following publications: (PMID: 25131394, 26857713) -

Feb 09, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly sequence Uncertain:1
Apr 20, 2018
Muenke lab, National Institutes of Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

While absent from public databases, this may be due to technical issues. At least 3 un-related probands (and one transmitting healthy parent) are positive for this missense change. Experimentally normal with ACMG criteria: BS3;PM2. No predictions for indel effects are given. -

FGF8-related disorder Benign:1
Mar 17, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Hypogonadotropic hypogonadism 6 with or without anosmia Benign:1
Nov 07, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
Mutation Taster
=75/25
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs762175290; hg19: chr10-103534939; API